Award
Delivery Order #SPE2DP26F2956
Delivery Order for Loperamide Hydrochloride under DMS Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$190.96
Ceiling
$190.96
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Feb 23, 2026
Identifier
SPE2DP26F2956
NAICS
424210
This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceuticals, focused on supplying the drug Loperamide Hydrochloride. It functions as a supplemental order under the existing definitive pharmaceutical supply contract awarded to DMS, reinforcing the agency's ongoing procurement of essential medications. The delivery order covers the provision of a specific pharmaceutical product used to manage diarrhea, ensuring timely availability to support healthcare treatments. This action contributes to the agency's strategic healthcare mission by maintaining a consistent supply chain for critical drugs. The order was placed within the framework of a competitive, long-term indefinite delivery vehicle contract, suggesting adherence to established procurement protocols. The period of performance is brief, spanning a couple of days, indicating a prompt fulfillment requirement. This delivery order supports the broader pharmaceutical supply contract active since 2025, demonstrating continued collaboration between the government and DMS Pharmaceutical Group to meet public health needs.
Description
8511936142!LOPERAMIDE HYDROCHL